+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Levodopa"

Lewy Body Dementia Treatment Market Report 2025 - Product Thumbnail Image

Lewy Body Dementia Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
Parkinson's Disease Drugs - Global Strategic Business Report - Product Thumbnail Image

Parkinson's Disease Drugs - Global Strategic Business Report

  • Report
  • August 2025
  • 382 Pages
  • Global
From
CNS Therapeutics - Global Strategic Business Report - Product Thumbnail Image

CNS Therapeutics - Global Strategic Business Report

  • Report
  • August 2025
  • 898 Pages
  • Global
From
Levodopa-Induced Dyskinesia (LID) - Pipeline Insight, 2025 - Product Thumbnail Image

Levodopa-Induced Dyskinesia (LID) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Multiple System Atrophy- Pipeline Insight, 2025 - Product Thumbnail Image

Multiple System Atrophy- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Parkinson's Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Parkinson's Disease - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 280 Pages
  • Global
From
Dyskinesia- Pipeline Insight, 2025 - Product Thumbnail Image

Dyskinesia- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Spinocerebellar Ataxias - Pipeline Insight, 2025 - Product Thumbnail Image

Spinocerebellar Ataxias - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Progressive Supranuclear Palsy- Pipeline Insight, 2025 - Product Thumbnail Image

Progressive Supranuclear Palsy- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Lewy Body Disease- Pipeline Insight, 2025 - Product Thumbnail Image

Lewy Body Disease- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
From
From
From
Parkinsons Disease (PD) Drugs Market 2025-2029 - Product Thumbnail Image

Parkinsons Disease (PD) Drugs Market 2025-2029

  • Report
  • June 2025
  • 209 Pages
  • Global
From
Parkinson's Disease Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Parkinson's Disease Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Parkinson's Disease Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Parkinson's Disease Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
Parkinson's Disease Market Report and Forecast 2025-2034 - Product Thumbnail Image

Parkinson's Disease Market Report and Forecast 2025-2034

  • Report
  • June 2025
  • 400 Pages
  • Global
From
Loading Indicator

Levodopa is a drug used to treat Parkinson's disease, a neurological disorder that affects movement. It is a dopamine precursor, meaning it is converted into dopamine in the brain, which helps to reduce the symptoms of Parkinson's. Levodopa is usually taken in combination with other drugs, such as carbidopa, to increase its effectiveness. It is one of the most commonly prescribed drugs for Parkinson's, and is often the first line of treatment. Levodopa is a part of the larger Central Nervous System (CNS) drug market, which includes drugs used to treat a variety of neurological disorders. The CNS drug market is highly competitive, with many different companies offering various treatments. Some of the companies in the Levodopa market include Merck, Novartis, Teva Pharmaceuticals, and Sun Pharmaceuticals. Show Less Read more